# Ingles Markets Inc: overview

IMKTA · Nasdaq · CIK 50493 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Sep 26

Pages: [Overview](/companies/imkta.md) · [Financials](/companies/imkta/financials.md) · [Filings](/companies/imkta/filings.md) · [Insiders](/companies/imkta/insiders.md)

Latest reported revenue: [$1.37bn](/filings/0000050493-26-000020.md) for Q3 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0000050493-26-000020).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,398 d](/filings/0000050493-25-000019.md) | [1,288](/filings/0000050493-26-000010.md) | [1,331](/filings/0000050493-26-000013.md) | [1,346](/filings/0000050493-26-000020.md) | [1,368 d](/filings/0000050493-25-000019.md) | [1,373](/filings/0000050493-26-000010.md) | [1,308](/filings/0000050493-26-000013.md) | [1,368](/filings/0000050493-26-000020.md) |
| Gross margin | % | [21.4% d](/filings/0000050493-25-000019.md) | [23.4%](/filings/0000050493-26-000010.md) | [23.4%](/filings/0000050493-26-000013.md) | [24.3%](/filings/0000050493-26-000020.md) | [24.5% d](/filings/0000050493-25-000019.md) | [24.4%](/filings/0000050493-26-000010.md) | [24.9%](/filings/0000050493-26-000013.md) | [24.3%](/filings/0000050493-26-000020.md) |
| Operating margin | % | [(0.1%) d](/filings/0000050493-25-000019.md) | [1.8%](/filings/0000050493-26-000010.md) | [1.6%](/filings/0000050493-26-000013.md) | [2.8%](/filings/0000050493-26-000020.md) | [2.6% d](/filings/0000050493-25-000019.md) | [2.9%](/filings/0000050493-26-000010.md) | [2.6%](/filings/0000050493-26-000013.md) | [2.5%](/filings/0000050493-26-000020.md) |
| Net margin | % | [(0.1%) d](/filings/0000050493-25-000019.md) | [1.3%](/filings/0000050493-26-000020.md) | [1.1%](/filings/0000050493-26-000020.md) | [1.9%](/filings/0000050493-26-000020.md) | [1.9% d](/filings/0000050493-25-000019.md) | [2.0%](/filings/0000050493-26-000020.md) | [1.9%](/filings/0000050493-26-000020.md) | [1.9%](/filings/0000050493-26-000020.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [5.4 d](/filings/0000050493-25-000019.md) | [(81.4)](/filings/0000050493-26-000010.md) | [38.9 d](/filings/0000050493-26-000013.md) | [45.4 d](/filings/0000050493-26-000020.md) | [36.8 d](/filings/0000050493-25-000019.md) | [2.1](/filings/0000050493-26-000010.md) | [67.1 d](/filings/0000050493-26-000013.md) | [43.6 d](/filings/0000050493-26-000020.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-09-25) | FY2022 (2022-09-24) | FY2023 (2023-09-30) | FY2024 (2024-09-28) | FY2025 (2025-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,988](/filings/0000050493-23-000021.md) | [5,679](/filings/0000050493-24-000018.md) | [5,893](/filings/0000050493-25-000019.md) | [5,640](/filings/0000050493-25-000019.md) | [5,334](/filings/0000050493-25-000019.md) |
| Gross margin | % | [26.1%](/filings/0000050493-23-000021.md) | [24.9%](/filings/0000050493-24-000018.md) | [23.8%](/filings/0000050493-25-000019.md) | [23.0%](/filings/0000050493-25-000019.md) | [23.9%](/filings/0000050493-25-000019.md) |
| Operating margin | % | [7.0%](/filings/0000050493-23-000021.md) | [6.6%](/filings/0000050493-24-000018.md) | [5.0%](/filings/0000050493-25-000019.md) | [2.6%](/filings/0000050493-25-000019.md) | [2.2%](/filings/0000050493-25-000019.md) |
| Net margin | % | [5.0%](/filings/0000050493-23-000021.md) | [4.8%](/filings/0000050493-24-000018.md) | [3.6%](/filings/0000050493-25-000019.md) | [1.9%](/filings/0000050493-25-000019.md) | [1.6%](/filings/0000050493-25-000019.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [166](/filings/0000050493-23-000021.md) | [220](/filings/0000050493-24-000018.md) | [92.8](/filings/0000050493-25-000019.md) | [51.7](/filings/0000050493-25-000019.md) | [39.6](/filings/0000050493-25-000019.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/imkta/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $120.2m | 1,356,805 |  | Added +80,500 |
| [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $111.6m | 1,260,027 |  | Added +7,743 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $82.8m | 935,060 |  | Added +18,882 |
| [River Road Asset Management, LLC](/funds/1341401.md) | 2026-06-30 | $81.1m | 915,990 |  | Reduced −40,430 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $67.8m | 765,346 |  | Added +124,101 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $56.1m | 633,339 |  | Added +10,402 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $51.0m | 576,284 |  | Added +26,325 |
| [GAMCO INVESTORS, INC. ET AL](/funds/807249.md) | 2026-06-30 | $48.6m | 548,931 |  | Reduced −24,960 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $48.1m | 542,553 |  | Added +79,844 |
| [Summer Road LLC](/funds/1604873.md) | 2026-06-30 | $38.4m | 433,678 |  | Unchanged |

## Recent filings

[All 570 filings](/companies/imkta/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 16:15 ET | [8-K](/filings/0001437749-26-030320.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030320 |
| 2026-08-06 | 16:35 ET | [10-Q](/filings/0000050493-26-000020.md) | Quarterly report, period 2026-06-27 | 0000050493-26-000020 |
| 2026-08-06 | 07:35 ET | [8-K](/filings/0001437749-26-026048.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-026048 |
| 2026-08-04 | 16:16 ET | [8-K](/filings/0001437749-26-025666.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-025666 |
| 2026-05-07 | 16:19 ET | [10-Q](/filings/0000050493-26-000013.md) | Quarterly report, period 2026-03-28 | 0000050493-26-000013 |
| 2026-05-07 | 07:35 ET | [8-K](/filings/0001437749-26-015353.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-015353 |
| 2026-05-05 | 16:06 ET | [8-K](/filings/0001437749-26-014872.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-014872 |
| 2026-02-05 | 16:11 ET | [10-Q](/filings/0000050493-26-000010.md) | Quarterly report, period 2025-12-27 | 0000050493-26-000010 |
| 2026-02-05 | 07:35 ET | [8-K](/filings/0001437749-26-003091.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-003091 |
| 2026-01-22 | 16:15 ET | [10-K/A](/filings/0000050493-26-000006.md) | Annual report, amended, period 2025-09-27 | 0000050493-26-000006 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 27, 2025](/filings/0000050493-25-000019.md), filed Nov 26, 2025.

## Forecast league

Q4 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c3313833-1826-4c0e-a2a1-49d71582e473)

## About the filer

- CIK: 50493
- Tickers: IMKTA
- Exchange: Nasdaq
- SIC code: 5411 Retail-Grocery Stores
- State of incorporation: NC
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.